Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Epstein-Barr virus LMP2A signaling in statu nascendi mimics a B cell antigen receptor-like activation signal.

Engels N, Yigit G, Emmerich CH, Czesnik D, Schild D, Wienands J.

Cell Commun Signal. 2012 Apr 3;10:9. doi: 10.1186/1478-811X-10-9.

3.
4.

The Epstein-Barr virus protein, latent membrane protein 2A, co-opts tyrosine kinases used by the T cell receptor.

Ingham RJ, Raaijmakers J, Lim CS, Mbamalu G, Gish G, Chen F, Matskova L, Ernberg I, Winberg G, Pawson T.

J Biol Chem. 2005 Oct 7;280(40):34133-42. Epub 2005 Aug 8.

6.
7.

Epstein-Barr virus latent membrane protein 2A (LMP2A) employs the SLP-65 signaling module.

Engels N, Merchant M, Pappu R, Chan AC, Longnecker R, Wienands J.

J Exp Med. 2001 Aug 6;194(3):255-64.

9.

Epstein-Barr virus latent membrane protein 2A contributes to anoikis resistance through ERK activation.

Iwakiri D, Minamitani T, Samanta M.

J Virol. 2013 Jul;87(14):8227-34. doi: 10.1128/JVI.01089-13. Epub 2013 May 22.

10.

Epstein-Barr virus protein LMP2A regulates reactivation from latency by negatively regulating tyrosine kinases involved in sIg-mediated signal transduction.

Miller CL, Lee JH, Kieff E, Burkhardt AL, Bolen JB, Longnecker R.

Infect Agents Dis. 1994 Apr-Jun;3(2-3):128-36. Review.

PMID:
7812651
11.

Latent membrane protein 2B regulates susceptibility to induction of lytic Epstein-Barr virus infection.

Rechsteiner MP, Berger C, Zauner L, Sigrist JA, Weber M, Longnecker R, Bernasconi M, Nadal D.

J Virol. 2008 Feb;82(4):1739-47. Epub 2007 Dec 5.

12.

Epstein-Barr virus latent membrane protein-2A induces ITAM/Syk- and Akt-dependent epithelial migration through αv-integrin membrane translocation.

Fotheringham JA, Coalson NE, Raab-Traub N.

J Virol. 2012 Oct;86(19):10308-20. doi: 10.1128/JVI.00853-12. Epub 2012 Jul 25.

13.
14.

Epstein-Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigen.

Swanson-Mungerson MA, Caldwell RG, Bultema R, Longnecker R.

J Virol. 2005 Jun;79(12):7355-62.

15.

Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.

Vockerodt M, Wei W, Nagy E, Prouzova Z, Schrader A, Kube D, Rowe M, Woodman CB, Murray PG.

J Pathol. 2013 Aug;230(4):399-409. doi: 10.1002/path.4198.

PMID:
23592216
16.

Epstein-Barr virus latent membrane protein 2A activates beta-catenin signaling in epithelial cells.

Morrison JA, Klingelhutz AJ, Raab-Traub N.

J Virol. 2003 Nov;77(22):12276-84.

17.
18.

Silencing of latent membrane protein 2B reduces susceptibility to activation of lytic Epstein-Barr virus in Burkitt's lymphoma Akata cells.

Rechsteiner MP, Berger C, Weber M, Sigrist JA, Nadal D, Bernasconi M.

J Gen Virol. 2007 May;88(Pt 5):1454-9.

PMID:
17412973
19.

Epstein-barr virus latent membrane protein 2B (LMP2B) modulates LMP2A activity.

Rovedo M, Longnecker R.

J Virol. 2007 Jan;81(1):84-94. Epub 2006 Oct 11.

Supplemental Content

Support Center